The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Aciclovir Agepha 30 mg/g eye ointment

AGEPHA Pharma s.r.o.PA22584/001/001

Main Information

Trade NameAciclovir Agepha 30 mg/g eye ointment
Active SubstancesAciclovir
Dosage FormEye ointment
Licence HolderAGEPHA Pharma s.r.o.
Licence NumberPA22584/001/001

Group Information

ATC CodeS01AD03 aciclovir


License statusAuthorised
Licence Issued19/08/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back